San Jose, Calif., Dec. 19, 2012 – Ariosa Diagnostics, maker of the Harmony Prenatal Test, today announced that it will present at the 31st Annual JP Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, Jan. 9.

Dr. Ken Song, CEO of Ariosa Diagnostics, will provide an update on the company and its product portfolio at 3:00 p.m. in the Elizabethan CD 120 Room.

*The Harmony Prenatal Test is developed by Ariosa Diagnostics. Ariosa Diagnostics is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies.Non-invasive prenatal testing (NIPT) services based on cell-free DNA analyses are not diagnostic; results should be confirmed by diagnostic testing.Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.